Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Hepatocellular carcinoma (HCC) presents high mortality and limited treatment options, necessitating novel therapeutic targets.
• Noncoding RNAs (ncRNAs), including small and long ncRNAs, are increasingly recognized for their roles in cancer development.
• Understanding ncRNAs is vital for advancing hepatocellular carcinoma research.

Purpose of the Study:

• To review the characteristics and biological roles of ncRNAs in hepatocellular carcinoma (HCC).
• To evaluate the potential therapeutic applications of ncRNAs for HCC treatment.
• To highlight ncRNAs as promising targets for future HCC therapies.

Main Methods:

• Literature review of advanced RNA sequencing studies.
• Analysis of ncRNA expression patterns in HCC.
• Evaluation of functional studies on ncRNAs in liver cancer models.

Main Results:

• ncRNAs are significantly dysregulated in HCC and influence liver tumorigenesis.
• Specific ncRNAs demonstrate oncogenic or tumor-suppressive functions in HCC.
• ncRNAs offer potential as biomarkers and therapeutic agents for HCC.

Conclusions:

• ncRNAs are critical regulators in hepatocellular carcinoma development and progression.
• Targeting ncRNAs presents a promising strategy for novel HCC therapies.
• Further research into ncRNA mechanisms can lead to improved HCC management.